Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03656679 · ClinicalTrials.gov registry record · NA
Paravertebral Versus Pectoralis Block for Post Mastectomy Pain
A NA study, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT03656679 is a NA study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 18 participants.
The verdict
NCT03656679, a NA study, was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
Post-mastectomy pain affects more than half of patients undergoing the procedure and can last for years. It has been well established that development of chronic pain is related to experienced pain in the perioperative period. This study therefore aims to assess if both acute and chronic post-operative mastectomy pain can be better managed by a novel regional anesthesia nerve block known as the pectoralis block (PECs). The PECs block is easier for patients to position for placement, has less risk of harm to nearby structures, and less risk for systemic uptake of local anesthetic in comparison to the paravertebral block. The PECs block has a strong safety profile. Standard of care at University of Wisconsin (UW) hospital is to utilize regional anesthesia for post op pain management. While PVB is performed on a regular basis at UW per surgeon request, Surgeon can request for PECS block in patients where a PVB was contraindicated (ie. coagulation issues). PECS is in fact the standard of care at other hospitals. This study will assess outcomes in the post anesthetic care unit (PACU), post-operative day 1, 7 and 30.
Interventions
- PROCEDURE Pectoralis Blockade (PECs)
- PROCEDURE Paravertebral Blockade
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2018-10-18 |
| Est. Completion | 2020-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03656679
The ClinicalTrials.gov registry entry for NCT03656679 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pectoralis Blockade (PECs) is the first listed.
NCT03656679 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03656679 about?
NCT03656679 is a clinical study titled "Paravertebral Versus Pectoralis Block for Post Mastectomy Pain". Post-mastectomy pain affects more than half of patients undergoing the procedure and can last for years. It has been well established that development of chronic pain is related to experienced pain in the perioperative period. This study therefore aims to assess if both acute and chronic post-operat...
What is the current status of trial NCT03656679?
This trial is currently terminated. It is a NA study. The enrollment target is 18 participants. The study started on 2018-10-18. Estimated completion is 2020-02-28.
What interventions are being tested in trial NCT03656679?
The interventions under investigation include: Pectoralis Blockade (PECs) (PROCEDURE), Paravertebral Blockade (PROCEDURE).
Who is sponsoring clinical trial NCT03656679?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.